跳至主要内容
临床试验/CTRI/2023/02/049906
CTRI/2023/02/049906尚未招募2 期

Prophylactic romiplostim in pediatric subjects receiving myelosuppressive chemotherapy to hasten platelet recovery: An open-label randomized controlled trial - PROSPER

Dr. SHIVAM BANSA0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • a) Cancer patient aged 1 to 14 year
  • b) Requires block-based myelosuppressive chemotherapy
  • c) First cycle of chemotherapy for solid tumors
  • d) Induction course 2 chemotherapy for acute myeloid leukemia

排除标准

  • a) Presence of bony metastasis in solid tumors
  • b) Post induction course 1 chemotherapy, bone marrow not in complete remission or MRD more than 1% in AML
  • c) Received thrombopoietic agent in the past
  • d)Prior history of venous thromboembolism (VTE) or arterial thrombotic events
  • e) Subjects with non-consenting guardians

研究者

发起方
Dr. SHIVAM BANSA

相似试验